Derek Bagley, Author at Endocrine News

COVID-19 Pandemic Associated with Disruptions to Women’s Reproductive Health

Women’s reproductive health has been disrupted as a result of the psychological burden of the COVID-19 pandemic, and affected women need additional medical and psychological support, according to research presented at the Society for Endocrinology annual conference in Edinburgh last November. The findings indicate that stress and sleep disturbance related to the pandemic have had...

Abbott, ADA Launch Community Initiative to Advance Access to Diabetes Care and Technology

Last November, Abbott and the American Diabetes Association (ADA) announced the launch of their first joint community health partnership. The community initiative, which is the first program under the ADA’s Health Equity Now platform, will launch in Columbus, Ohio, and be conducted in partnership with the National Center for Urban Solutions (NCUS), a Columbus-based organization...

2021 Progress Report: Part 2

Endocrine research remains at the forefront of medical breakthroughs, which has led to cutting-edge treatment options, therapies, and products. Here is part 2 of Endocrine News’s closer look at some of the endocrine science innovations announced throughout 2021. Endocrine researchers and clinicians continued to remain at the forefront of medical research, the result of which...

2021 Progress Report: Part 1

Endocrine research remains at the forefront of medical breakthroughs, which has led to cutting-edge treatment options, therapies, and products. From remarkable new treatments for acromegaly, thyroid eye disease, hypoglycemia, and diabetes to new devices aimed at glucose monitoring in adults and children, a mail-in semen analysis kit, and much more, Endocrine News takes a closer...

Postmenopausal Women May Benefit from Estrogen Compound Research

Postmenopausal women have increased risk of non-alcoholic fatty liver disease due to loss of estrogen from metabolic changes. A high-fat diet further exacerbates the disease, which can progress to cirrhosis and liver failure. Hormone replacement therapy (HRT) is an effective treatment, but it carries increased risk of breast cancer, uterine cancers, and cardiovascular disease. Researchers...

European Medicine Agency’s CHMP Grants Positive Opinion to Long-Acting Growth Hormone for Patients with Pediatric Growth Hormone Deficiency

In November, the European Medicine Agency’s Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion recommending the granting of a marketing authorization for Ascendis Pharma’s lonapegsomatropin (TransCon hGH), a long-acting once-weekly, transiently pegylated somatropin that in the body releases somatropin, indicated for growth failure in children and adolescents aged from 3 years...

The Highest Rates of Severe Hypoglycemia Crises Are in Patients with Diabetes and End-Stage Kidney Disease, Study Finds

In patients who have diabetes and end-stage kidney disease (ESKD), the rates of severe hypoglycemia crises requiring emergency department visits or hospitalizations are the highest so far reported, according to a nationwide study recently published in Diabetes Care. Researchers led by Rodolfo J. Galindo, MD, FACE, associate professor of medicine at Emory University School of...

COVID-19 May Trigger Hyperglycemia and Worsen Disease by Harming Fat Cells

COVID-19 may bring high risks of severe disease and death in many patients by disrupting key metabolic signals and thereby triggering hyperglycemia, according to a new study in Cell Metabolism. Researchers led by James C. Lo, MD, PhD, an associate professor of medicine in the Weill Center for Metabolic Health and the Cardiovascular Research Institute at Weill Cornell Medicine and a cardiologist at NewYork-Presbyterian/Weill Cornell Medical Center, found that hyperglycemia is common in hospitalized COVID-19 patients and...